To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

AstraZeneca1,270 enrolled

Overview

The purpose of this study is to study the changes in protein in lung cells of Asian patients with advanced non small cell lung cancer.

A molecular epidemiology study in Asian patients with advanced NSCLC of adeno histology to assess EGFR mutation status.

Study Type

INTERVENTIONAL

Allocation

Purpose

SCREENING

Masking

NONE

Enrollment

1,270

Conditions

Non Small Cell Lung Cancer

Interventions

Testing for mutation statusPROCEDURE

EGFR mutation test

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Histological or cytologically confirmed advanced Non small cell lung cancer of adeno histology NSCLC treatment naive Availability of cancer tissue or cytology sample Exclusion Criteria: * Involvement in the planning and/or conduct of the study Previous enrollment in the present study

Locations (36)

Outcomes

Primary Outcomes

EGFR mutation status of Asian patients with advanced NSCLC

Time frame: Samples will be tested after informed consent. Mutation results will be available within 1-3 weeks.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.